Timing is everything: new trial tests when to give extra immune cells after transplant to fight leukemia relapse
NCT ID NCT07319793
Summary
This study aims to find the best timing for giving extra donor immune cells to patients who have received a stem cell transplant for hard-to-treat blood cancers like leukemia. It will compare giving these cells as a preventive measure versus waiting and giving them only if early signs of cancer return are detected. The goal is to see which approach better prevents the cancer from coming back while managing side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.